Atlas Trials

Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)

Clinical trial NCT04180085 · RECRUITING

Trial details

NCT number
NCT04180085
Sponsor
Nantes University Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Transplant Failure
Start date
2020-02-06
Primary completion
2028-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.